[Effect of various kinds of therapy on T-cell activity in chronic lymphadenosis].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000368:Aged; D002469:Cell Separation; D002478:Cells, Cultured; D002699:Chlorambucil / Q000627:therapeutic use; D003562:Cytidine / Q000378:metabolism; D005260:Female; D006801:Humans; D037102:Lectins; D007945:Leukemia, Lymphoid / Q000532:radiotherapy / Q000628:therapy*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000528:radiation effects; D008297:Male; D008875:Middle Aged; D009929:Organ Size; D011830:Radiation Effects; D013154:Spleen / Q000473:pathology / Q000528:radiation effects; D013601:T-Lymphocytes / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014747:Vinblastine / Q000627:therapeutic use
D037102:Lectins; D014316:Tritium; D002699:Chlorambucil; D003562:Cytidine; D014747:Vinblastine; D000324:Adrenocorticotropic Hormone; D013936:Thymidine
Beeinflussung der T-Zellaktivität bei chronischer Lymphadenose durch verschiedene Therapieformen